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Liver Failure Group, Institute for Liver and Digestive Health, University College London, Royal Free Hospital, UKIt is with great pride, pleasure, and humility that I take over as
Editor in Chief of the Journal of Hepatology from Professor Didier
Samuel. It is of historical interest to note that the Editorial base of
the Journal is returning to the Royal Free Hospital in London
where it started 30 years ago by Dame Sheila Sherlock. From
the very humble beginnings, the Journal has had a rapid and
impressive growth, with an increase in impact factor from 4.97
in 2002 to 10.4 in 2013. This has occurred in parallel with the
amazing growth of the European Association for the Study of
Liver (EASL), which has become a truly International organiza-
tion, evidenced by the attendance of more than 10,000 registrants
from all over the world. Incidentally, 2014 is also the 50th anni-
versary of EASL. Over the past 5 years under Didier’s leadership,
the Journal has made huge progress, improving enormously its
readability, increasing the submission of original articles from
1600 to 2100 per year and the number of downloads from
600K to 1.1M. Of note, at present, 40% original articles originate
in Asia, 18% are from the USA and 36% are from Europe, indicating
the truly International nature of the Journal.
The current Editorial teamwill attempt to build further on this
success. The Journal will remain the forum for publication of new
scientiﬁc discoveries, novel clinical observations, evidence based
changes in treatment paradigms or any other advancements in
the understanding of liver pathobiology and disease. If an author
has great scientiﬁc, technical or clinical observations they want to
publish, they should think of the Journal of Hepatology ﬁrst. We
will continue to ensure that the process of submission is easy
and the peer-review process fair, rapid, and transparent. If you
have a great idea for a review, we encourage you to contact us
to see whether this is suitable for the Journal. As the number of
submissions to the Journal increases, unfortunately, many excel-
lent papers will not ﬁnd a place in the Journal. We are all aware
of the enormous amount of time one spends preparing a paper
for submission and then to receive an early rejection seems very
unfair. In order to make the submission process easy and quick,
we are therefore introducing a relatively painless submission pro-
cess; ‘Your paper, Your way’, which means that within reason, we
will review your paper without special requirements concerning
formatting of the article, references, ﬁgures, and tables, as long
as the scientiﬁc content of the paper can be evaluated. The new
guidelines for authors will describe these basic requirements.Journal of Hepatology 20
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Open access under CC BY-NC-ND license.We also recognize the need in a small number of cases for a
‘Fast-Track Review’ and rapid publication, whichwewill introduce.
This will be suitable for ‘breakthrough’ observations, high impact
clinical trials, and some exceptional scientiﬁc discoveries. A path-
way for such a Fast-Track Review is being introduced.
The large number of papers submitted from Asia is a reﬂection
of the burden of disease and increasing scientiﬁc enterprise in
these geographical areas. Despite the large number of papers sub-
mitted from Asia the acceptance rates are still relatively low. But
it is clear that the rates of acceptance are starting to increase and
no doubt, in the recent future, Asia will catch up with the West.
The Journal of Hepatology sees itself as a global journal tackling a
global problem. Understanding the differences in disease charac-
teristics and the inﬂuence of genetic, dietary, environmental, and
socio-political factors on the manifestations of liver diseases and
their treatment can provide a new understanding. In order to
make the contents of the Journal available to a larger audience,
we have launched a Chinese and a Russian translation of the Jour-
nal. Furthermore, we are working on a proposal to start a section
that will focus on ‘Global issues in Hepatology’.
Governance in publication is a rapidly emerging important
issue, which the new team is taking seriously. In response to
the need, Professor Richard Moreau, who was an Editor with
the previous Editorial team will act as a Senior Editor, looking
at governance issues in relation to the Journal. Plagiarism and
unethical practices in science and publication are a sad but real
problem. Although, rebuttals regarding decisions made by the
Editorial Board are strongly discouraged, there will be occasional
cases where genuine mistakes have been made, and in a small
number of cases the Senior Editor will step in to review the deci-
sion making process. Conﬂicts of interest are an inevitable part of
life for an academic researcher or a clinician and Professor Mor-
eau will ensure, that when these are present, they are fully
declared and adequate provisions are made to guarantee that
the authors get a fair peer-review.
I will be helped in running the Journal by Professor Jessica
Zucmann-Rossi, Professor Thomas Berg and Professor Ramon
Bataller, who are well-known experts in their own ﬁeld, and
will in most instances be responsible for papers dealing with
basic science and cancer; viral hepatitis; and alcoholic and
non-alcoholic fatty liver disease, respectively. They bring a huge
amount of energy, expertise, scientiﬁc brilliance, and imagina-
tion, which I hope indicates to the submitting authors that
we are ready to engage with high-quality basic science, while
maintaining a very strong clinical focus and a full dedication
to editorial excellence. Fig. 1 describes the complete list of15 vol. 62 j 1–3
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Fig. 1. Complete list of Associate Editors, Special Section Editors, and the Editorial team.
Editorialthe Associate Editors, Special Section Editors, and the Editorial
team, who are all leaders in their chosen ﬁeld. The Journal
ofﬁce is based in Geneva, co-located within the EASL ofﬁce. Joel
Walicki leads an amazing team supported by Ursula Loizides,
(Editorial Coordinator) and Sophie Jarlier (Graphic designer).
Sybrand Boer Iwema from Elsevier will provide us with the
publishing support.
There will be few changes in the format of the articles with
the modiﬁcation/introduction of new sections. These are brieﬂy
described below:
1. Original Articles.We recognize that although over 90% of scien-
tiﬁc articles ﬁt into a standard format available in the Journal,2 Journal of Hepatology 2about 10% do not. Taking this into account, we are introducing
four additional types of Original Articles:
a. Theory Articles: These articles will describe modelling
studies, which are mainly theoretical.
b. Resource Articles: These articles will describe technical
advances in science or in the practice of Hepatology.
c. Matters arising Articles: These articles will be specially
formatted to allow publication of papers that directly
contradict a previously published paper in the Journal of
Hepatology.
d. Brief Communications: They will be very high impact arti-
cles that concisely describe highly novel and innovative
ﬁndings.015 vol. 62 j 1–3
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2. Review Articles. Most review articles will be of the classical
type focussing on a given topic. In addition, we will introduce
the following new types of Review Articles:
a. Seminars: These will be larger review articles, focussed on
a broad subject, typically multi-authored, describing
basic, translational and clinical aspects of a problem.
b. Clinical Trial Watch: This section will be a description of
clinical trial activities, reported at specialized and large
International meetings. Articles should also focus on the
therapeutic aspects of speciﬁc diseases.
c. Pro-Con Debates: This section will be a pro-con debate on
relevant topics, written by two authors providing oppos-
ing views on a given topic. A pre-selected moderator will
provide introductory and concluding statements. All
three authors will share the ﬁnal authorship.
3. Grand Rounds in Hepatology: This section will mainly focus on
education and should include case based discussions. Articles
are usually by invitation only, but approaching the Editorial
ofﬁce with ideas is welcome. The idea for this section is that
articles are written by a multidisciplinary team rather than
an individual, reﬂecting the practice in Hepatology units, with
reference to the literature in case there are deviations.
4. Public Engagement and Affairs: We believe that articles
published in the Journal should be accessible to the lay public
or patients and as such wewill introduce a short ‘lay summary’
for each published paper. Also, we will introduce a new section
that will deal with Hepatology issues that are relevant to policy
makers or funders, or deal with issues that may allow
discussion about global issues in Hepatology.Journal of Hepatology 2It is clear to the team that the way we read articles in the Journal
has changed a lot over the past years with a rapid migration to
hand-held devices, such as mobile phones and tablets. The pub-
lisher and the Editorial team have worked hard to provide
bespoke solutions to improve the quality of articles on these
devices. We are aware that there is room for improvement, in
particular regarding readability of articles and the downloadable
web material. We have plans to address these requirements. In
addition, there are substantial plans to further improve the web
page, with the introduction of an expanded and more involved
role of the Web-Editors. We will try to put more effort into high-
lighting articles, using interviews with authors of papers and
provide focussed insights in an easily readable format.
Although EASL is already 50 years old, I see Hepatology as a
specialty that is just ‘coming of age’ because it is only now that
we are getting to grips with the pathobiology of disease, new
treatments are becoming available that have the potential to
change the way we practice Hepatology and provide for the ﬁrst
time real hope for patients. Therefore, I feel extremely privileged
to be in this amazing position of leading this great Journal in this
exciting time of positive growth. I am going to conclude by
thanking the many, many individuals, including my mentors,
my family, friends, and colleagues who have sacriﬁced a lot of
their time and energy to allow me to get to this point. Finally, I
want to thank the EASL Governing Board for giving me this
fantastic opportunity, responsibility, and honour.015 vol. 62 j 1–3 3
